<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1607245584
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Aprolin
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        HYDRALAZINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Hetero Labs Limited Unit &#x2013; III" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Hetero Labs Limited Unit – III
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2950]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Saudi Amarox
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Saudi Amarox
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C02DB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Hydralazine belongs to a group of medicines called vasodilators. These medicines relax the muscles of artery walls and cause blood vessels to expand.&nbsp;</p><p>Hydralazine tablets are used to:&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; treat moderate to severe high blood pressure (with or without a beta-blocker or diuretic medicine)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; manage moderate to severe congestive heart failure (where use of other medicines alone is not enough.<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take <strong>Hydralazine tablets if you have: </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>an </strong>allergy <strong>to hydralazine, dihydralazine or any of the other ingredients in this medicine (listed in section 6) </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>a </strong>racing heart beat <strong>(tachycardia) </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart failure <strong>caused by narrowing of blood vessels or heart valves (aortic or mitral stenosis), high blood pressure in blood vessels supplying the lungs (pulmonary hypertension) or inflammation of the heart (constrictive pericarditis) </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart failure <strong>with a normal or increased output of blood from the heart (e.g. in thyrotoxicosis) </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; systemic lupus erythematosus <strong>(SLE) or any related disease </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>swelling in a blood vessel wall </strong>(aortic aneurism)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>(or a relative has) an inherited disorder of the red blood pigment haemoglobin </strong>(porphyria).</p><p><strong>Warnings and precautions </strong>&nbsp;</p><p><strong>Talk to your doctor or pharmacist before taking Hydralazine tablets if you: </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>have had a </strong>heart attack <strong>in the past three months </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>have </strong>coronary heart disease</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have <strong>angina pectoris</strong>, which causes pain in the chest with exercise&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have <strong>cerebrovascular disease </strong>(narrowing of the blood vessels in the brain)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have been told you are a <strong>slow acetylator </strong>(this means that your body handles some medicines more slowly than other people)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from any <strong>serious liver or kidney problems</strong>.</p><p>&nbsp;<strong>Tests </strong>&nbsp;</p><p>If you are taking long-term Hydralazine treatment, your doctor may want to carry out blood and urine tests every 6 months.</p><p>&nbsp;<strong>Other medicines and Hydralazine tablets </strong>&nbsp;</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.&nbsp;</p><p>It is especially important to tell your doctor if you are taking:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for high blood pressure, such as vasodilators (e.g. minoxidil diazoxide)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ACE inhibitors (e.g. enalapril, lisinopril, captopril)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beta-blockers (e.g. propranolol)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calcium antagonists (e.g. nifedipine or diltiazem)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for water retention (e.g. diuretics)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for problems such as depression, including monoamine oxidase inhibitors</p><p>(MAOIs) (e.g. moclobemide, phenelzine, isocarboxazid, tranylcypromine)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tricyclic antidepressants (e.g. amitriptyline, clomipramine) or tranquillisers (e.g. diazepam)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to control pain and inflammation (a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs))</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines to control psychoses&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a specific group of medicines known as nitrates, used to control blood pressure&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; oestrogens (a group of female sex hormones used in contraception and in treating the menopause)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle relaxants (e.g. baclofen, tizonidine)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that stimulate the nervous system (e.g. adrenaline, norepinephrine)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; steroids.</p><p>&nbsp;If you are going to have <strong>general anaesthetic, </strong>you should tell the <strong>doctor or dentist </strong>in charge that you are taking Hydralazine tablets.</p><p><strong>Aprolin with alcohol </strong>&nbsp;</p><p>It is advisable not to drink alcohol whilst taking Hydralazine tablets as it may affect you more than usual.</p><p><strong>Pregnancy and breast-feeding </strong>&nbsp;</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, please tell your doctor before taking Hydralazine Tablets.</p><p><strong>Driving and using machines </strong>&nbsp;</p><p>You can drive while taking Hydralazine but do not drive until you know how the tablets affect you. They may make you feel dizzy. If they affect you in this way, <strong>do not </strong>drive or operate any machinery.</p><p><strong>Aprolin and lactose </strong>&nbsp;</p><p>If you have been told you have an intolerance to some sugars, contact your doctor before taking this medicine, as the Aprolin tablets contain lactose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Hydralazine tablets exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist</p><p>Speak to your doctor before drinking <strong>alcohol </strong>with this medicine.</p><p>&nbsp;<strong>Swallow these tablets </strong>with water.</p><p>The recommended dose is:<strong> </strong></p><p><strong>Adults (including the elderly): </strong>&nbsp;</p><p><strong>Hypertension: </strong>Initially 25mg twice a day or 50mg once a day. Your doctor may gradually increase this, up to a maximum of 200mg a day. Your doctor will decide on the best dose for you.&nbsp;</p><p><strong>Chronic congestive heart failure: </strong>Treatment should be started in hospital and dosages can vary.</p><p>The maintenance dose is 50mg - 75mg four times a day.<strong> </strong></p><p><strong>Use in children: </strong>Not recommended.</p><p><strong>If you take more Aprolin than you should </strong>&nbsp;</p><p>If you (or someone else) swallow a lot of the tablets at the same time, or if you think a child may have swallowed any, contact your nearest hospital casualty department or tell your doctor immediately.&nbsp;</p><p>Symptoms of an overdose include low blood pressure, racing heart beat, decreased blood flow to the heart, irregular heartbeat, coma.<sub> </sub></p><p><strong>If you forget to take Aprolin </strong>&nbsp;</p><p>Do not take a double dose to make up for a forgotten dose. If you forget to take a dose, take it as soon as you remember it and then take the next dose at the right time.</p><p><strong>If you stop taking Aprolin </strong>&nbsp;</p><p><strong>Do not stop </strong>treatment early because an increase in blood pressure may occur. <strong>Talk to your doctor </strong>before you stop taking the tablets and follow their advice.&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.<strong> </strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<strong> </strong></p><p>Stop taking the medicine and seek immediate medical advice if you notice the following:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SLE-type syndrome, which can cause symptoms such as joint pain, fever, change in blood count and skin rash.&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions including itching, skin rash, inflammation of the walls of small blood vessels and difficulty in breathing. <strong>&nbsp;</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Yellowing of the skin and whites of the eyes, which may indicate problems with the liver such as jaundice and hepatitis.</p><p><strong>Other side effects may include: </strong>&nbsp;</p><p><strong>Very common (may affect more than 1 in 10 people) </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal heart beat (palpitations)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An unusually fast heart beat&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headaches.</p><p><strong>Common (may affect up to 1 in 10 people) </strong>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pains&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swelling and/or pain in joints, muscle pain&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Low blood pressure&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling sick and being sick, particularly at the beginning of the treatment or after an increase in dose&nbsp; &bull; Diarrhoea</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flushing.</p><p>Uncommon (may affect up to 1 in 100 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heart failure, swelling&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased levels of substances called creatinine in the blood&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Breathlessness, breathing difficulties or pain when breathing&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood in the urine which may be associated with a disease of the kidneys&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Presence of protein in the urine&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation or the abnormal functioning of the liver&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Watering or sore itchy eyes&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A reduction in the number of platelets in the blood which can cause unexplained bruising or rashes&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A reduction in certain white blood cells which may make you more susceptible to infections&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increase in other kinds of white blood cells&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anxiety&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Restlessness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blocked or stuffy nose&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Weight loss&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Generally feeling unwell.</p><p>&nbsp;Rare (may affect up to 1 in 1,000 people)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney failure&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A change in the amount of urine produced&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A restriction of movement in part of the intestine&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A deficiency of certain white blood cells which can result in fever and ulceration of the mouth and throat&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increased number of white blood cells&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enlargement of the spleen&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A reduction in the number of red and white blood cells and platelets in the blood&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depression&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Seeing or hearing things which are not really there (hallucinations)&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the nerves which may cause weakness or numbness especially in your fingers and toes&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tingling (pins and needles) in your hands or feet&nbsp; &bull; Disease of the lymph nodes&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Enlarged eye balls.</p><p>If you feel very tired, experience unexpected bruising or bleeding, or more infections (e.g. colds and sore throats) than usual please tell your doctor. Your doctor may decide to conduct tests on your blood periodically as a result of these symptoms.</p><p>Reporting of side effects&nbsp;&nbsp;</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia<em>: </em></strong></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o SFDA Call Center: 19999</p><p>&nbsp;o E-mail: npc.drug@sfda.gov.sa</p><p>o&nbsp; Website: www.sfda.gov.sa/npc &nbsp;</p><p>o&nbsp; <strong><em>Other GCC States: </em></strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>keep this medicine out of the sight and reach of children.&nbsp;</p><p>Do not store above 25&deg;C. Store in the original container..&nbsp;</p><p>The expiry date refers to the last day of that month.</p><p>This medicine does not require any special storage conditions.</p><p>do not throw away any medicines via wastewater or household waste. ask your pharmacist how to throw away medicines you no longer use. these measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Aprolin contains </strong></p><p><strong>Aprolin 10 mg, 25 mg, 50 mg and 100 mg:&nbsp; </strong></p><p>The active substance is Hydralazine Hydrochloride.</p><p>Each uncoated Tablet contains Hydralazine Hydrochloride USP 10 mg</p><p>Each uncoated Tablet contains Hydralazine Hydrochloride USP 25 mg</p><p>Each uncoated Tablet contains Hydralazine Hydrochloride USP 50 mg</p><p>Each uncoated Tablet contains Hydralazine Hydrochloride USP 100 mg</p><p><strong><u>Hydralazine Hydrochloride&nbsp; Tablets 10 mg,25 mg, 50 mg and 100 mg:</u></strong><strong> </strong></p><p>Anhydrous Lactose (Super Tab 21 AN), Sodium Starch Glycolate (Primojel), Microcrystalline</p><p>Cellulose, (Avicel PH 112), FD&amp;.c Yellow# 61 Sunset yellow FCF AL 15%-18%, IH and Stearic Acid, USP/NF (Speziol L2 SM GFPHA.)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Hydralazine Hydrochloride Tablets 10 mg:  
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘38’ on another side. 
 
Hydralazine Hydrochloride Tablets 25 mg:  
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘39’ on another side. 
 
Hydralazine Hydrochloride Tablets 50 mg: 
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘40’ on another side. Hydralazine Hydrochloride Tablets 100 mg: 
Orange, round, Unscored tablets debossed with 'H' on one side and '41' on another side. 
 
How supplied: 
Hydralazine Hydrochloride Tablets 10 mg, 25 mg, 50 mg and 100 mg are supplied in Bottle pack. 
Hydralazine Hydrochloride Tablets 10 mg, 25 mg, 50 mg and 100 mg – HDPE bottle of 100 Tablets. 
 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Saudi Amarox Industrial Company,</strong></p><p>Aljameah Street, Malaz quarter, Riyadh 11441</p><p>Saudi Arabia</p><p>Tel: +966 11 477 2215</p><p><strong>Manufacturer </strong></p><p>Hetero Labs Limited Unit-III</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                September, 2021 
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي أبرولين على مادة الهيدرالازين والتي تنتمي إلى مجموعة من الأدوية تسمى موسعات الأوعية الدموية. تعمل هذه الأدوية على إرخاء عضلات جدران الشرايين وتسبب تمدد الأوعية الدموية.</p><p dir="RTL">تستخدم أقراص أبرولين في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج ارتفاع ضغط الدم المتوسط إلى الشديد (مع أو بدون حاصرات بيتا أو الأدوية المدرة للبول)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علاج قصور القلب الاحتقاني المتوسط إلى الشديد (حيث لا يكفي استخدام الأدوية الأخرى وحدها).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عدم تتناول أقراص أبرولين إذا كان لديك:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية تجاه هيدرالازين ، ثنائي الهيدرالازين أو أي من المكونات الأخرى في هذا الدواء (المدرجة في القسم 6)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع ضربات القلب (عدم انتظام دقات القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قصور القلب الناجم عن تضيق الأوعية الدموية أو صمامات القلب (تضيق الأبهر أو الصمام التاجي) ، أو ارتفاع ضغط الدم في الأوعية الدموية التي تغذي الرئتين (ارتفاع ضغط الدم الرئوي) أو التهاب القلب (التهاب التامور الانقباضي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قصور القلب مع خروج طبيعي أو متزايد للدم من القلب (على سبيل المثال في الانسمام الدرقي (التسمم الدرقي))</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الذئبة الحمامية الجهازية (SLE) أو أي مرض متعلق بها</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في جدار الأوعية الدموية (تمدد الأوعية الدموية الأبهري)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (إذا كان لديك أو لدى أحد الأقارب) اضطراب وراثي في صبغة الدم الحمراء الهيموجلوبين (البورفيريا).</p><p dir="RTL"><strong>التحزيرات والإحتياطات</strong></p><p dir="RTL">يجب التحدث إلى طبيبك أو الصيدلي قبل تناول أقراص أبرولين في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد أصيبت بنوبة قلبية في الأشهر الثلاثة الماضية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض القلب التاجي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الذبحة الصدرية التي تسبب ألمًا في الصدر مع ممارسة الرياضة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك مرض دماغي وعائي (تضيق الأوعية الدموية في الدماغ)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تم إخبارك بأنك من المؤستلين البطيئين (وهذا يعني أن جسمك يتعامل مع بعض الأدوية بشكل أبطأ من غيره)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أي مشاكل خطيرة في الكبد أو الكلى.</p><p dir="RTL"><strong>&nbsp;الاختبارات</strong></p><p dir="RTL">إذا كنت تتناول أقراص أبرولين كعلاج طويل الأمد ، فقد يرغب طبيبك في إجراء اختبارات للدم والبول كل 6 أشهر.</p><p dir="RTL"><strong>تناول الأدوية الأخرى و</strong><strong> </strong><strong>أبرولين</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى.</p><p dir="RTL">من المهم بشكل خاص أن تخبر طبيبك إذا كنت تتناول:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية ارتفاع ضغط الدم ، مثل موسعات الأوعية (مثل مينوكسيديل ديازوكسيد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات الإنزيم المحول للأنجيوتنسين (مثل إنالابريل وليزينوبريل وكابتوبريل)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات بيتا (مثل بروبرانولول)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الكالسيوم (مثل نيفيديبين أو ديلتيازيم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج احتباس الماء (مثل مدرات البول)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج بعض المشاكل مثل الاكتئاب ، بما في ذلك مثبطات مونوامين أوكسيديز (MAOIs) (مثل موكلوبميد ، فينيلزين ، إيزوكاربوكسازيد ، ترانيلسيبرومين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الاكتئاب ثلاثية الحلقات (مثل أميتريبتيلين وكلوميبرامين) أو المهدئات (مثل الديازيبام)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية للسيطرة على الألم والالتهابات (مجموعة من الأدوية تعرف باسم العقاقير الغير الستيرويدية المضادة للالتهابات (NSAIDs))</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية للسيطرة على مرض الذهان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مجموعة معينة من الأدوية تعرف بالنترات وتستخدم للتحكم في ضغط الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإستروجين (مجموعة من الهرمونات الجنسية الأنثوية المستخدمة في منع الحمل وعلاج إنقطاع الطمث)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الباسطة للعضلات (مثل باكلوفين وتيزونيدين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تحفز الجهاز العصبي (مثل الأدرينالين والنورادرينالين)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; منشطات.</p><p dir="RTL">&nbsp;إذا كنت ستخضع لتخدير عام ، يجب أن تخبر الطبيب أو طبيب الأسنان المسؤول أنك تتناول أقراص أبرولين.</p><p dir="RTL"><strong>تناول أقراص أبرولين مع الكحول</strong></p><p dir="RTL">يُنصح بعدم شرب الكحول أثناء تناول أقراص أبرولين لأنها قد تؤثر عليك أكثر من المعتاد.</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنت حاملاً أو مرضعة ، أو تعتقدين أنك حامل أو تخططين لإنجاب طفل ، فيرجى إخبار طبيبك قبل تناول أقراص أبرولين.</p><p dir="RTL"><strong>القيادة واستخدام الألات</strong></p><p dir="RTL">يمكنك القيادة أثناء تناول أبرولين ولكن لا تقم بالقيادة حتى تعرف كيف تؤثر الأقراص عليك. قد تجعلك تشعر بالدوار. إذا أثرت عليك بهذه الطريقة ، فلا تقود أو تشغل أي آلة.</p><p dir="RTL"><strong>محتوي</strong><strong> </strong><strong>أبرولين</strong><strong> </strong><strong>من اللاكتوز</strong></p><p dir="RTL">إذا أخبرك طبيبك أنك لا تتحمل بعض السكريات (مثل اللاكتوز) ، فاتصل بطبيبك قبل تناول هذا الدواء ، حيث تحتوي أقراص أبرولين على اللاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دائمًا على تناول أقراص أبرولين كما أخبرك طبيبك أو الصيدلي تماما ، استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p dir="RTL">تحدث إلى طبيبك قبل شرب الكحول مع هذا الدواء.</p><p dir="RTL"><strong>ابتلع هذه الأقراص بالماء.</strong></p><p dir="RTL"><strong>الجرعة الموصي بها هي:</strong></p><p dir="RTL"><strong>الكبار (بما في ذلك كبار السن):</strong></p><p dir="RTL"><strong>ارتفاع ضغط الدم</strong>: في البداية 25 ملغم مرتين في اليوم أو 50 ملغم مرة في اليوم. قد يزيد طبيبك من هذا تدريجياً ، بحد أقصى 200 ملغم في اليوم. سيقرر طبيبك أفضل جرعة لك.</p><p dir="RTL"><strong>قصور القلب الاحتقاني المزمن</strong>: يجب أن يبدأ العلاج في المستشفى ويمكن أن تختلف الجرعات. جرعة المداومة هي 50 ملغم - 75 ملغم أربع مرات في اليوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام في الأطفال</strong>: لا ينصح به.</p><p dir="RTL"><strong>إذا تناولت جرعة زائدة من أبرولين أكثر مما ينبغي</strong></p><p dir="RTL">إذا ابتلعت (أو أي شخص آخر) الكثير من الأقراص في نفس الوقت ، أو إذا كنت تعتقد أن طفلًا قد ابتلع أيًا منها ، فاتصل بأقرب قسم إصابة في المستشفى أو أخبر طبيبك على الفور.</p><p dir="RTL">تشمل أعراض الجرعة الزائدة انخفاض ضغط الدم ، وسرعة ضربات القلب ، وانخفاض تدفق الدم إلى القلب ، وعدم انتظام ضربات القلب ، والغيبوبة.</p><p dir="RTL"><strong>إذا نسيت أن تتناول</strong><strong> </strong><strong>أبرولين</strong></p><p dir="RTL">لا تأخذ جرعة مضاعفة لتعويض الجرعة المنسية. إذا نسيت أن تتناول جرعة ، فتناولها بمجرد أن تتذكرها ثم تناول الجرعة التالية في الوقت المناسب.</p><p dir="RTL"><strong>إذا توقفت عن تناول</strong><strong> </strong><strong>أبرولين</strong></p><p dir="RTL"><strong>لا تتوقف</strong> عن العلاج مبكرًا لأنه قد يحدث ارتفاع في ضغط الدم<strong>. تحدث إلى طبيبك</strong> قبل التوقف عن تناول الأقراص واتبع نصائحه.</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء ، اسأل طبيبك أو الصيدلي&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية ، يمكن أن يسبب هذا الدواء آثارًا جانبية ، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">توقف عن تناول الدواء واطلب المشورة الطبية فورًا إذا لاحظت ما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة من نوع (ذئبة حمامية مجموعية) SLE ، والتي يمكن أن تسبب أعراضًا مثل آلام المفاصل والحمى وتغير في تعداد مكونات الدم والطفح الجلدي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل التحسسية بما في ذلك الحكة والطفح الجلدي والتهاب جدران الأوعية الدموية الصغيرة وصعوبة في التنفس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد وبياض العين مما قد يشير إلى مشاكل في الكبد مثل اليرقان والتهاب الكبد.</p><p dir="RTL"><strong>الآثار الجانبية الأخرى قد تشمل:</strong></p><p dir="RTL"><strong>شائع جدًا (قد يصيب أكثر من شخص من كل 10 أشخاص)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم انتظام ضربات القلب (الخفقان)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تسارع ضربات القلب بشكل غير عادي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع.</p><p dir="RTL"><strong>شائعة (قد تظهر لدى ما يصل إلى شخص من كل 10 أشخاص)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام في الصدر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم و / أو ألم في المفاصل وآلام في العضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضغط دم منخفض</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالإعياء والمرض ، خاصة في بداية العلاج أو بعد زيادة الجرعة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL"><strong>غير شائعة (قد تظهر لدى ما يصل إلى شخص من كل 100 شخص)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل القلب ، تورم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات مواد تسمى الكرياتينين في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس ، صعوبات التنفس أو الألم عند التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور دم في البول قد يترافق مع مرض في الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود البروتين في البول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب أو خلل في وظائف الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة في العيون أو أن تصبح العيون دامعة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد الصفائح الدموية في الدم مما قد يؤدي إلى ظهور كدمات أو طفح جلدي غير مبرر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في بعض خلايا الدم البيضاء مما قد يجعلك أكثر عرضة للإصابة بالعدوى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في أنواع أخرى من خلايا الدم البيضاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قلق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خمول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد الأنف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الوزن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بتوعك بشكل عام.</p><p dir="RTL">نادرة (قد تظهر لدى <strong>ما يصل إلى شخص</strong> من كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل كلوي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيير في كمية البول المنتجة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقييد الحركة في جزء من الأمعاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص بعض خلايا الدم البيضاء الذي يمكن أن يؤدي إلى الحمى وتقرح الفم والحلق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة عدد خلايا الدم البيضاء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم الطحال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم الحمراء والبيضاء والصفائح الدموية في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كآبة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رؤية أو سماع أشياء غير موجودة بالفعل (هلوسة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأعصاب الذي قد يسبب الضعف أو التنميل خاصة في أصابع اليدين والقدمين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز (شعور بالوخذ) في يديك أو قدميك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض الغدد الليمفاوية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم كرات العين.</p><p dir="RTL">إذا كنت تشعر بالتعب الشديد ، أو تعاني من كدمات أو نزيف غير متوقع ، أو عدوى أكثر من المعتاد (مثل نزلات البرد والتهاب الحلق) ، فيرجى إخبار طبيبك. قد يقرر طبيبك إجراء فحوصات على دمك بشكل دوري نتيجة لهذه الأعراض.</p><p dir="RTL"><strong>&nbsp;التبليغ عن الأعراض الجانبية</strong></p><p>&nbsp;إذا زادت حدة أي من هذه الأعراض الجانبية ، أو لاحظت ظهور أعراض جانبية غير ما تم ذكره في هذه النشرة ، يرجى إبلاغ الطبيب المعالج أو الصيدلي. وهذا يشمل أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضا الإبلاغ عن الآثار الجانبية مباشرة (انظر التفاصيل أدناه). بالإبلاغ عن الآثار الجانبية يمكنك المساعدة في توفير مزيد من المعلومات حول أمان هذا الدواء.</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:608px"><tbody><tr><td style="vertical-align:top"><p dir="LTR"><!--[if mso & !supportInlineShapes & supportFields]><span
  style='mso-element:field-begin;mso-field-lock:yes'></span><span
  style='mso-spacerun:yes'> </span>SHAPE <span
  style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:
  field-separator'></span><![endif]--><!--[if gte vml 1]><v:shapetype id="_x0000_t202"
   coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
   <v:stroke joinstyle="miter"/>
   <v:path gradientshapeok="t" o:connecttype="rect"/>
  </v:shapetype><v:shape id="Text_x0020_Box_x0020_3" o:spid="_x0000_s1026"
   type="#_x0000_t202" style='width:453.6pt;height:90.7pt;visibility:visible;
   mso-wrap-style:square;mso-left-percent:-10001;mso-top-percent:-10001;
   mso-position-horizontal:absolute;mso-position-horizontal-relative:char;
   mso-position-vertical:absolute;mso-position-vertical-relative:line;
   mso-left-percent:-10001;mso-top-percent:-10001;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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==
" fillcolor="#e4e4e4" strokeweight=".5pt">
   <v:fill opacity="16962f"/>
   <v:textbox inset="7.45pt,3.85pt,7.45pt,3.85pt">
    <![if !mso]>
    <table cellpadding=0 cellspacing=0 width="100%">
     <tr>
      <td><![endif]>
      <div>
      <p class=MsoNormal align=center style='text-align:center'><b><span
      lang=AR-SA dir=RTL style='font-size:9.0pt;line-height:107%;font-family:
      "Arial",sans-serif;mso-bidi-theme-font:minor-bidi'>للإبلاغ عن الأعراض
      الجانبية<o:p></o:p></span></b></p>
      <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:.5in;
      margin-bottom:0in;margin-left:0in;text-align:right;text-indent:-.25in;
      line-height:normal;mso-list:l2 level1 lfo2;direction:rtl;unicode-bidi:
      embed'><![if !supportLists]><b style='mso-ansi-font-weight:normal'><span
      style='font-size:9.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:
      "Times New Roman"'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </span></span></span></b><![endif]><span dir=RTL></span><b><span
      lang=AR-SA style='font-size:9.0pt;font-family:"Arial",sans-serif;
      mso-bidi-theme-font:minor-bidi'>المملكة العربية السعودية</span></b><b><span
      dir=LTR style='font-size:9.0pt;font-family:"Arial",sans-serif;mso-bidi-theme-font:
      minor-bidi'><o:p></o:p></span></b></p>
      <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:.5in;
      margin-bottom:0in;margin-left:0in;text-align:right;text-indent:-.25in;
      line-height:normal;mso-list:l2 level1 lfo2;direction:rtl;unicode-bidi:
      embed'><![if !supportLists]><b style='mso-ansi-font-weight:normal'><span
      style='font-size:9.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:
      "Times New Roman"'><span style='mso-list:Ignore'>-<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </span></span></span></b><![endif]><span dir=RTL></span><b><span
      lang=AR-SA style='font-size:9.0pt;font-family:"Arial",sans-serif;
      mso-bidi-theme-font:minor-bidi'>المركز الوطني للتيقظ والسلامة الدوائية</span></b><b><span
      dir=LTR style='font-size:9.0pt;font-family:"Arial",sans-serif;mso-bidi-theme-font:
      minor-bidi'><o:p></o:p></span></b></p>
      <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:32.35pt;
      margin-bottom:0in;margin-left:0in;text-align:justify;text-indent:-14.2pt;
      line-height:normal;mso-list:l0 level1 lfo3;tab-stops:list 0in;direction:
      rtl;unicode-bidi:embed'><![if !supportLists]><span class=q4iawc><span
      style='font-size:9.0pt;font-family:"Courier New";mso-fareast-font-family:
      "Courier New"'><span style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </span></span></span></span><![endif]><span dir=RTL></span><span
      lang=AR-EG style='font-size:9.0pt;font-family:"Arial",sans-serif;
      mso-bidi-theme-font:minor-bidi;mso-bidi-language:AR-EG'>مر</span><span
      lang=AR-SA style='font-size:9.0pt;font-family:"Arial",sans-serif;
      mso-bidi-theme-font:minor-bidi'>كز الاتصال بالهيئة العامة للغذاء والدواء:
      19999</span><span class=q4iawc><span lang=AR-SA style='font-size:13.5pt;
      font-family:"Arial",sans-serif;mso-ascii-font-family:Roboto;mso-hansi-font-family:
      Roboto;mso-bidi-theme-font:minor-bidi;color:black;background:whitesmoke'>
      </span></span><span class=q4iawc><span dir=LTR style='font-size:9.0pt;
      font-family:"Arial",sans-serif;mso-bidi-theme-font:minor-bidi'><o:p></o:p></span></span></p>
      <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:32.35pt;
      margin-bottom:0in;margin-left:0in;text-align:justify;text-indent:-14.2pt;
      line-height:normal;mso-list:l0 level1 lfo3;tab-stops:list 0in;direction:
      rtl;unicode-bidi:embed'><![if !supportLists]><span style='font-size:9.0pt;
      font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
      style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
      style='font-size:9.0pt;font-family:"Arial",sans-serif;mso-bidi-theme-font:
      minor-bidi'>البريد الإلكتروني : </span><a
      href="mailto:npc.drug@sfda.gov.sa"><span dir=LTR style='font-size:9.0pt;
      font-family:"Arial",sans-serif;mso-bidi-theme-font:minor-bidi'>npc.drug@sfda.gov.sa</span></a><span
      lang=AR-SA style='font-size:9.0pt;font-family:"Arial",sans-serif;
      mso-bidi-theme-font:minor-bidi'><o:p></o:p></span></p>
      <p class=MsoNormal dir=RTL style='margin-top:0in;margin-right:32.35pt;
      margin-bottom:0in;margin-left:0in;text-align:justify;text-indent:-14.2pt;
      line-height:normal;mso-list:l0 level1 lfo3;tab-stops:list 0in;direction:
      rtl;unicode-bidi:embed'><![if !supportLists]><span style='font-size:9.0pt;
      font-family:"Courier New";mso-fareast-font-family:"Courier New"'><span
      style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
      </span></span></span><![endif]><span dir=RTL></span><span lang=AR-SA
      style='font-size:9.0pt;font-family:"Arial",sans-serif;mso-bidi-theme-font:
      minor-bidi'>الموقع الإلكتروني: </span><span dir=LTR style='font-size:
      9.0pt;font-family:"Arial",sans-serif;mso-bidi-theme-font:minor-bidi'>www.sfda.gov.sa/npc</span><span
      lang=AR-SA style='font-size:9.0pt;font-family:"Arial",sans-serif;
      mso-bidi-theme-font:minor-bidi'><o:p></o:p></span></p>
      </div>
      <![if !mso]></td>
     </tr>
    </table>
    <![endif]></v:textbox>
   <w:wrap type="none" anchorx="page"/>
   <w:anchorlock/>
  </v:shape><![endif]--><img width="611" height="127" alt="Text Box: للإبلاغ عن الأعراض الجانبية
-	المملكة العربية السعودية
-	المركز الوطني للتيقظ والسلامة الدوائية
o	مركز الاتصال بالهيئة العامة للغذاء والدواء: 19999 
o	البريد الإلكتروني : npc.drug@sfda.gov.sa
o	الموقع الإلكتروني: www.sfda.gov.sa/npc
" src="file:///C:/Users/Pc/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" /><!--[if gte vml 1]><v:shapetype
   id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
   path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
   <v:stroke joinstyle="miter"/>
   <v:formulas>
    <v:f eqn="if lineDrawn pixelLineWidth 0"/>
    <v:f eqn="sum @0 1 0"/>
    <v:f eqn="sum 0 0 @1"/>
    <v:f eqn="prod @2 1 2"/>
    <v:f eqn="prod @3 21600 pixelWidth"/>
    <v:f eqn="prod @3 21600 pixelHeight"/>
    <v:f eqn="sum @0 0 1"/>
    <v:f eqn="prod @6 1 2"/>
    <v:f eqn="prod @7 21600 pixelWidth"/>
    <v:f eqn="sum @8 21600 0"/>
    <v:f eqn="prod @7 21600 pixelHeight"/>
    <v:f eqn="sum @10 21600 0"/>
   </v:formulas>
   <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
   <o:lock v:ext="edit" aspectratio="t"/>
  </v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><v:shape
   id="_x0000_i1025" type="#_x0000_t75" style='width:453.6pt;height:90.7pt'>
   <v:imagedata croptop="-65520f" cropbottom="65520f"/>
  </v:shape><span style='mso-element:field-end'></span><![endif]--></p><p dir="LTR"><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><p dir="LTR">&nbsp;يرجى الاتصال بالسلطة الصحية المختصة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن رؤية ومتناول أيدي الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب أن يحفظ في درجة حرارة لا تزيد عن 25 درجة مئوية و يجب التخزين في العلبة الأصلية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة ، يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; هذا الدواء لا يتطلب أي شروط تخزين خاصة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما يحتويه أبرولين أقراص</strong></p><p dir="RTL">أبرولين 10 ملغم ، 25 ملغم ، 50 ملغم ، 100 ملغم:</p><p dir="RTL">المادة الفعالة لأبرولين أقراص هي هيدروكلوريد الهيدرالازين</p><p dir="RTL">يحتوي كل قرص أبرولين 10 ملغم غير مغلف على 10 ملغم هيدروكلوريد الهيدرالازين المتوافق مع دستور الأدوية الأمريكي.</p><p dir="RTL">يحتوي كل قرص أبرولين 25 ملغم غير مغلف على 25 ملغم هيدروكلوريد الهيدرالازين المتوافق مع دستور الأدوية الأمريكي.</p><p dir="RTL">يحتوي كل قرص أبرولين 50 ملغم غير مغلف على 50 ملغم هيدروكلوريد الهيدرالازين المتوافق مع دستور الأدوية الأمريكي.</p><p dir="RTL">يحتوي كل قرص أبرولين 100 ملغم غير مغلف على 100 ملغم هيدروكلوريد الهيدرالازين المتوافق مع دستور الأدوية الأمريكي.</p><p dir="RTL"><strong>الصواغات الأخرى:</strong></p><p dir="RTL">اللاكتوز اللامائي (Super Tab 21 AN) ، نشا الصوديوم جلايكولات (Primojel) ، السليلوز دقيق التبلور ، (Avicel PH 112) ، صبغة صفراء FD &amp; .c Yellow # 61 Sunset Yellow FCF AL 15٪ -18٪ ، IH وحمض الستياريك ، USP / NF ( Speziol L2 SM GFPHA.)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong><u>أقراص أبرولين 10 ملغم:</u></strong></p><p dir="RTL">أقراص برتقالية ، مستديرة ، غير قابلة للتقسيم مدموغ عليها بحرف &quot;H&quot; على جانب و &quot;38&quot; على جانب آخر.</p><p dir="RTL"><strong><u>أقراص أبرولين 25 ملغم:</u></strong></p><p dir="RTL">أقراص برتقالية ، مستديرة ، غير قابلة للتقسيم مدموغ عليها بحرف &quot;H&quot; على جانب و &quot;39&quot; على الجانب الآخر.</p><p dir="RTL"><strong><u>أقراص أبرولين 50 ملغم:</u></strong></p><p dir="RTL">أقراص برتقالية ، مستديرة ، غير قابلة للتقسيم مدموغ عليها بحرف &quot;H&quot; على جانب و &quot;40&quot; على جانب آخر.</p><p dir="RTL"><strong><u>أقراص أبرولين 100 ملغم:</u></strong></p><p dir="RTL">أقراص برتقالية ، مستديرة ، غير قابلة للتقسيم مدموغ عليها بحرف &quot;H&quot; على جانب و &quot;41&quot; على جانب آخر.</p><p dir="RTL"><strong>كيف تتوفر</strong><strong>:</strong></p><p dir="RTL">&nbsp;يتم توفير أبرولين 10 ملغم ، 25 ملغم ، 50 ملغم ، 100 ملغم في عبوة بلاستيكية مصنعة من بولي ايثيلين&nbsp;عالي الكثافة .</p><p dir="RTL">وتحتوي كل عبوة أبرولين 10 ملغم ، 25 ملغم ، 50 ملغم ، 100 ملغم أقراص على 100 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شركة أماروكس الصناعية السعودية </strong></p><p>شارع الجامعة &ndash; الملز &ndash; الرياض12629</p><p>المملكة العربية السعودية.</p><p dir="RTL">تليفون: &nbsp;+ 966 112268850</p><p><strong>المصنع</strong></p><p dir="RTL">شركة هتيرو لاب المحدودة وحدة-III</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم الموافقة على هذه النشرة بتاريخ سبتمبر 2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aprolin (Hydralazine Hydrochloride Tablets USP 10 mg, 25 mg, 50 mg and 100 mg)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aprolin (Hydralazine Hydrochloride Tablets 10 mg):
Each uncoated Tablet contains Hydralazine Hydrochloride USP 10 mg
Aprolin (Hydralazine Hydrochloride Tablets 25 mg):
Each uncoated Tablet contains Hydralazine Hydrochloride USP 25 mg
Aprolin (Hydralazine Hydrochloride Tablets 50 mg):
Each uncoated Tablet contains Hydralazine Hydrochloride USP 50 mg
Aprolin (Hydralazine Hydrochloride Tablets 100 mg):
Each uncoated Tablet contains Hydralazine Hydrochloride USP 100 mg

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aprolin (Hydralazine Hydrochloride Tablets 10 mg):
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘38’ on another side.
Aprolin (Hydralazine Hydrochloride Tablets 25 mg):
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘39’ on another side.
Aprolin (Hydralazine Hydrochloride Tablets 50 mg):
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘40’ on another side.
Aprolin (Hydralazine Hydrochloride Tablets 100 mg):
Orange, round, Unscored tablets debossed with ‘H’ on one side and ‘41’ on another side.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydralazine is indicated for:</p><p>1)&nbsp; Moderate to severe hypertension as an adjunct to other anti-hypertensive agents.</p><p>&nbsp;</p><p>&nbsp;</p><p>Due to the complementary mechanism of action the combination of hydralazine with b-blockers and diuretics may enable antihypertensive efficacy at lower dose levels and counteract accompanying hydralazine effects such as reflex tachycardia and oedema.</p><p>2)&nbsp; As supplementary medication for use in combination with long-acting nitrates in moderate to severe chronic congestive cardiac failure in patients in whom optimal doses of conventional therapy have proved insufficient.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u> <em>Adults Hypertension</em></p><p>The dose should be adjusted to the individual requirements of the patient. Treatment should begin with low doses of hydralazine which, depending on the patient&#39;s response should be increased stepwise to achieve optimal therapeutic effect whilst keeping unwanted effects to a minimum. Initially 50mg once daily. This can be increased gradually to a dose not exceeding 200mg daily.</p><p>The dose should not be increased beyond 100mg daily without first checking the patient&#39;s acetylator status.</p><p><em>Chronic congestive heart failure:</em></p><p>Treatment with hydralazine should always be initiated in hospital, where the patient&#39;s individual haemodynamic values can be reliably determined with the help of invasive monitoring. It should then be continued in hospital until the patient has become stabilised on the requisite maintenance dose. Doses vary greatly between individual patients and are generally higher than those used for treating hypertension. After progressive titration (initially 50mg twice daily increasing every second day) the maintenance dosage averages 50-75mg four times daily.</p><p><em>Paediatric population</em></p><p>Not recommended for this age group.</p><p><em>Elderly</em></p><p>Clinical evidence indicates that no special dosage regime is necessary. Advancing age does not affect either blood concentration or systemic clearance. Renal elimination may however be affected in so far as kidney function diminishes with age.</p><p><u>Method of administration</u> For oral administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Hypersensitivity to hydralazine, dihydralazine or to any of the excipients listed in section 6.1.
•	Idiopathic system lupus erythematosus (SLE) and related diseases.
•	Severe tachycardia
•	In heart failure associated with high cardiac output (i.e. in thyrotoxicosis).
•	Myocardial insufficiency due to mechanical obstruction e.g. in the presence of aortic or mitral stenosis or constrictive pericarditis).
•	Isolated right ventricular failure due to pulmonary hypertension (ie cor pulmonale).
•	Dissecting aortic aneurism.
•	Porphyria.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Warnings</em></p><p>The overall &#39;hyperdynamic&#39; state of the circulation induced by hydralazine may accentuate certain clinical conditions. Myocardial stimulation may provoke or aggravate angina pectoris. Patients with suspected or confirmed coronary artery disease should therefore be given Hydralazine 50mg Tablets BP only under cover of beta-blocker or in combination with other suitable sympatholytic agents. It is important that the beta-blocker medication should be commenced a few days before the start of treatment with Hydralazine 50mg Tablets BP.</p><p>Patients who have survived a myocardial infarction should not receive Hydralazine 50mg Tablets BP until a post-infarction stabilisation <em>state </em>has been achieved.</p><p>Prolonged treatment with hydralazine (i.e. usually for more than 6 months) may provoke a systemic lupus erythematosus (SLE)-like syndrome, especially where doses exceed 100 mg daily. First symptoms are likely to be similar to rheumatoid arthritis (arthralgia, sometimes associated with fever, anaemia, leucopenia, thrombocytopenia and rash) and are reversible after withdrawal of the drug. In its more severe form it resembles acute SLE (similar manifestations as the milder form plus pleurisy, pleural effusions and pericarditis), and in rare cases renal and ocular involvement have been reported. Early detection and a timely diagnosis with appropriate therapy (i.e. treatment discontinuation and possibly long-term treatment with corticosteroids may be required to reverse these changes) are of utmost importance in this life-threatening illness to prevent more severe complications, which may sometimes be fatal.</p><p>Since such reactions tend to occur more frequently the higher the dose and the longer its duration, and since they are also more common in slow acetylators, it is recommended that for maintenance therapy the lowest effective dose should be used. If 100 mg daily fails to elicit an adequate clinical effect, the patient&#39;s acetylator status should be evaluated. Slow acetylators and women run greater risk of developing the SLE-like syndrome and every effort should therefore be made to keep the dosage below 100 mg daily and a careful watch kept for signs and symptoms suggestive of this syndrome. If such symptoms do develop the drug should be gradually withdrawn.</p><p>&nbsp;</p><p>&nbsp;</p><p>Rapid acetylators often respond inadequately even to doses of 100 mg daily and therefore the dose can be raised with only a slightly increased risk of an LE like syndrome.</p><p>During long term treatment with Hydralazine 50mg Tablets BP it is advisable to determine the antinuclear factors and conduct urine analysis at intervals of approximately 6 months. Microhaematuria and / or proteinuria, in particular together with positive titres of ANF, may be initial signs of immune-complex glomerulonephritis associated with the SLE like syndrome. If overt clinical signs or symptoms develop, the drug should be withdrawn immediately.</p><p>Skin rash, febrile reactions and change in blood count occur rarely and drug should be withdrawn. Peripheral neuritis in the form of paraesthesia has been reported, and may respond to pyridoxine administration or drug withdrawal.</p><p><em>Precautions</em></p><p>In patients with renal impairment (creatinine clearance &lt; 30 ml/min or serum creatinine concentrations &gt; 2.5 mg / 100 ml or 221 &mu;mol/l) and in patients with hepatic dysfunction the dose or interval between doses should be adjusted according to clinical response, in order to avoid accumulation of the &#39;apparent&#39; active substance.</p><p>Hydralazine 50mg Tablets BP should be used with caution in patients with coronary artery disease (since it may increase angina) or cerebrovascular disease.</p><p>When undergoing surgery, patients treated with Hydralazine 50mg Tablets BP may show a fall in blood pressure, in which case one should not use adrenaline to correct the hypotension, since it enhances the cardiac-accelerating effects of hydralazine.</p><p>When initiating therapy in heart failure, particular caution should be exercised and the patient kept under surveillance and/or haemodynamic monitoring for early detection of postural hypotension or tachycardia. Where discontinuation of therapy in heart failure is indicated, Hydralazine 50mg Tablets BP should be withdrawn gradually (except in serious situations, such as SLE-like syndrome or blood dyscrasias) in order to avoid precipitation and/or exacerbation of heart failure.</p><p>Hydralazine 50mg tablets contain carmoisine aluminium lake azorubine (E122) which may cause allergic reactions.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Potentiation of effects</em></strong></p><p>Concurrent therapy with other antihypertensives (vasodilators, calcium antagonists, ACE inhibitors, diuretics), muscle relaxants (baclofen and tizonidine), anaesthetics, tricyclic antidepressants, major tranquillisers, nitrates or drugs exerting central depressant actions (including alcohol).</p><p>Administration of Hydralazine 50mg Tablets BP shortly before or after diazoxide may give rise to marked hypotension.</p><p>&nbsp;</p><p>&nbsp;</p><p>MAO inhibitors should be used with caution in patients receiving Hydralazine 50mg Tablets BP.</p><p>Concurrent administration of Hydralazine 50mg Tablets BP with beta-blockers subject to a strong first pass effect (e.g. propranolol) may increase their bioavailability. Downward adjustment of these drugs may be required when they are given concomitantly with Hydralazine 50mg Tablets BP.</p><p>There is potential for the hypotensive effect of hydralazine to be antagonised when used concomitantly with oestrogens or non-steroidal anti-inflammatory drugs.</p><p><strong><em>Reduction in effects</em></strong></p><p>Concomitant treatment with sympathomimetics, tricyclic antidepressants, NSAIDs, corticosteroids</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Use of Hydralazine in pregnancy, before the third trimester should be avoided but the drug may be employed in later pregnancy if there is no safer alternative or when the disease itself carries serious risks for the mother or child e.g. pre-eclampsia and or eclampsia.</p><p>No serious adverse effects in human pregnancy have been reported to date with Hydralazine, although experience in the third trimester is extensive.</p><p><u>Breast-feeding</u></p><p>Hydralazine passes into breast milk but reports available so far have not shown adverse effects on the infant Mothers in whom use of Hydralazine is unavoidable may breast feed their infant provided that the infant is observed for possible adverse effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydralazine may impair the patient&#39;s reactions especially at the start of the treatment. The patient should be warned of the hazard when driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some of the adverse effects listed below e.g. tachycardia, palpitations, angina symptoms, flushing, headache, dizziness, nasal congestion and gastro-intestinal disturbances are commonly seen at the start of treatment, especially if the dose is raised quickly. However such effects generally subside in the further course of treatment.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Very common (&ge;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Common (&ge;1/100 to &lt;1/10)</strong></p></td><td style="vertical-align:top"><p><strong>Uncommon (&ge;1/1,000 to &lt;1/100)</strong></p></td><td style="vertical-align:top"><p><strong>Rare (&ge;1/10,000 to</strong></p><p><strong>&lt;1/1,000)</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Blood and lymphatic system</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>anaemia, leucopenia, neutropenia,</p></td><td style="vertical-align:top"><p>haemolytic anaemia, leucocytosis,</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>thrombocytopenia with or without purpura</p></td><td style="vertical-align:top"><p>lymphadenopathy, pancytopenia, splenomegaly, agranulocytosis</p></td></tr><tr><td style="vertical-align:top"><p><em>Psychiatric disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>agitation, anorexia, anxiety</p></td><td style="vertical-align:top"><p>depression, hallucinations</p></td></tr><tr><td style="vertical-align:top"><p><em>Nervous system disorder</em></p></td><td style="vertical-align:top"><p>headache</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>dizziness</p></td><td style="vertical-align:top"><p>peripheral neuritis, polyneuritis, paraesthesiae (these unwanted effects may be reversed by administering pyridoxine)</p></td></tr><tr><td style="vertical-align:top"><p><em>Eye disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>increased lacrimation, conjunctivitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Cardiac disorders</em></p></td><td style="vertical-align:top"><p>tachycardia, palpitations</p></td><td style="vertical-align:top"><p>flushing, hypotension, anginal symptoms</p></td><td style="vertical-align:top"><p>oedema, heart failure</p></td><td style="vertical-align:top"><p>paradoxical pressor responses</p></td></tr><tr><td style="vertical-align:top"><p><em>Respiratory, thoracic and mediastinal disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>nasal congestion, dyspnoea, pleural pain</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Gastrointestinal disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>gastro-intestinal disturbances, diarrhoea, nausea, vomiting</p></td><td style="vertical-align:top"><p>jaundice, liver enlargement, abnormal liver function sometimes in association with hepatitis</p></td><td style="vertical-align:top"><p>paralytic ileus</p></td></tr><tr><td style="vertical-align:top"><p><em>Skin and subcutaneous tissue disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>rash</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Musculoskeletal and connective tissue disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>arthralgia, joint swelling, myalgia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><em>Renal and Urinary disorders</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>proteinuria, increased plasma creatinine, haematuria sometimes in association with glomerulonephritis</p></td><td style="vertical-align:top"><p>acute renal failure, urinary retention, glomerulonephritis</p></td></tr><tr><td style="vertical-align:top"><p><em>General disorders and administration</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>SLE-like syndrome (sometimes resulting in a fatal</p></td><td style="vertical-align:top"><p>hypersensitivity reactions such as pruritus, urticaria,</p></td><td style="vertical-align:top"><p>exophthalmos, rheumatoid arthritis</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>site conditions</em></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>outcome. See section 4.4)</p></td><td style="vertical-align:top"><p>vasculitis, eosinophilia, hepatitis, fever, weight decrease, malaise, anti- neutrophil cytoplasmic antibody positive vasculitis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>&nbsp;</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions (see details below)</p><p><u>Reporting of suspected adverse reactions</u></p><p>&nbsp;</p><p>&bull;&nbsp; Saudi Arabia<em>:</em></p><p><strong><em>&nbsp;</em></strong></p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="_x0000_s2050" type="#_x0000_t202" style='position:absolute;
  margin-left:68.35pt;margin-top:10.95pt;width:477.6pt;height:97.5pt;z-index:-251653120;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' filled="f" strokeweight=".21069mm">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoBodyText style='margin-top:0in;margin-right:161.6pt;
     margin-bottom:0in;margin-left:6.4pt;margin-bottom:.0001pt;line-height:
     185%;tab-stops:24.15pt'>The National Pharmacovigilance and Drug Safety
     Centre<span style='letter-spacing:-1.6pt'> </span>(NPC) o<span
     style='mso-tab-count:1'>    </span>-mail: <a
     href="mailto:npc.drug@sfda.gov.sa"><span style='color:blue;text-decoration:
     none;text-underline:none'>npc.drug@sfda.gov.sa</span></a><o:p></o:p></p>
     <p class=MsoBodyText style='margin-left:6.4pt;tab-stops:28.15pt'>o<span
     style='mso-tab-count:1'>     </span>ebsite:<span style='letter-spacing:
     -.05pt'> </span><a href="http://www.sfda.gov.sa/npc"><span
     style='color:blue;text-decoration:none;text-underline:none'>www.sfda.gov.sa/npc</span></a><o:p></o:p></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="641" height="134" alt="Text Box: The National Pharmacovigilance and Drug Safety Centre (NPC) o	-mail: npc.drug@sfda.gov.sa
o	ebsite: www.sfda.gov.sa/npc
" src="file:///C:/Users/Lenovo/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr></tbody></table><p><!--[if gte vml 1]></o:wrapblock><![endif]--></p><p>&nbsp;</p><p><strong><em>&nbsp;</em></strong></p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>o Other GCC States:</strong></p><p><strong>&nbsp;</strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Signs and symptoms</u></p><p>Symptoms including hypotension, tachycardia, myocardial ischaemia, dysrrhythmias and coma. <u>Treatment</u></p><p>Gastric lavage or, in the absence of coma, emetic treatment should be given as soon as possible. Supportive measures such as intravenous fluids and elevation of foot of bed are also indicated. If hypotension is present, an attempt should be made to raise blood pressure without increasing</p><p>&nbsp;</p><p>&nbsp;</p><p>tachycardia, hence adrenaline (epinephrine) should be avoided. Cautious administration of angiotensin or noradrenaline (norepinephrine) intravenously may be of use.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Hydrazinophthalazine derivatives; ATC code: C02D B02</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Hydralazine is a direct acting vasodilator which exerts its effects principally on the arterioles. Its precise mode of action is not known.</p><p><u>Pharmacodynamic effects</u></p><p>Administration of hydralazine produces a fall in peripheral resistance and a decrease in arterial blood pressure, effects which induce reflex sympathetic cardiovascular responses. The concomitant use of a beta-blocker will reduce these reflex effects and enhance the anti- hypertensive effect. The use of hydralazine can result in sodium and fluid retention, producing oedema and reduced urinary volume. These effects can be prevented by concomitant administration of a diuretic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u></p><p>Orally administered Hydralazine is rapidly and completely absorbed but is subject to a dose dependent first pass effect (systemic bioavailability: 26-55%) which is dependent upon the individual&#39;s acetylator status. Peak plasma concentrations are attained after 0.5 to 1.5 hours.</p><p><u>Distribution</u></p><p>Hydralazine is rapidly distributed in the body and displays a particular affinity for the blood vessel walls. Plasma protein binding is of the order of 90%. Within 24 hours after an oral dose, the quantity recovered in the urine averages 80% of the dose.</p><p><u>Biotransformation</u> Nil.</p><p><u>Elimination</u></p><p>Hydralazine appears in the plasma chiefly in the form of a readily hydrolysable conjugate with pyruvic acid. Plasma half-life averages 2-3 hours but is prolonged up to 16 hours in severe renal failure (creatinine clearance less than 20 ml/mm) and shortened to approximately 45 minutes in rapid acetylators.</p><p>The bulk of the dose is excreted as acetylated and hydroxylated metabolites, some of which are conjugated with glucoronic acid.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Characteristics in patients</u> None relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hydralazine has been found to be teratogenic in mice producing a small incidence of cleft palate and certain other bony malformations, in oral doses ranging from 20-120 mg / kg i.e. 20-30 times the maximum human daily dose. It was not teratogenic in rats or rabbits.</p><p>In high (cyto-) toxic concentrations, hydralazine induces gene mutations in single cell organisms and in mammalian cells in vitro. No unequivocally mutagenic effects have been detected in vivo in a great number of test systems.</p><p>Hydralazine in lifetime carcinogenicity studies, caused, towards the end of the experiments, small but statistically significant increases in lung tumours in mice and in hepatic and testicular tumours in rats. These tumours also occur spontaneously with fairly high frequency in aged rodents.</p><p>With due consideration of these animals and in-vitro toxicological findings, hydralazine in therapeutic doses does not appear to bear risk that would necessitate a limitation of its administration. Many years of clinical experience have not suggested that human cancer is associated with hydralazine use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Aprolin Hydralazine Hydrochloride Tablets 10mg, 25mg, 50mg and 10 mg:</u></strong></p><p><strong>&nbsp;</strong></p><p>Anhydrous Lactose (Super Tab 21 AN), Sodium Starch Glycolate (Primojel), Microcrystalline Cellulose, (Avicel PH 112), FD&amp;.c Yellow# 61 Sunset yellow FCF AL 15%-18%, IH and Stearic Acid, USP/NF (Speziol L2 SM GFPHA.)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>HDPE Container pack</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Saudi Amarox Industrial Company,
Aljameah Street, Malaz quarter, Riyadh 12629, Saudi Arabia
Tel: +966 11 226 8850
Manufacture: Annora Pharma Private Limited, India

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May-2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>